McCollough steps down as St Jude group president
This article was originally published in Clinica
Joseph McCollough has stepped down as group president of St Jude Medical and is retiring from the company. He first joined the firm in 1994 as regional sales director for its cardiac rhythm management (CRM) division – he took on the role of group president in January 2008, overseeing St Jude's US and international divisions and its corporate brand and global marketing functions. Subsequent to his departure, Michael Rousseau, current group president for CRM, will assume responsibility for the US division. Mr Rousseau, who Morgan Stanley analyst David Lewis described as "the natural choice" in succession, had previously ran St Jude's US operations from 2002-08. It is anticipated that his experience could potentially boost the firm's performance in the US, where its CRM and atrial fibrillation franchises have faltered over the last two quarters, noted Mr Lewis. The international division, which is managed by Denis Gestin, will report directly to St Jude president, CEO and chairman Daniel Starks.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.